C2 domain-containing phosphoprotein CDP138 regulates GLUT4 insertion into the plasma membrane

Cell Metab. 2011 Sep 7;14(3):378-89. doi: 10.1016/j.cmet.2011.06.015.

Abstract

The protein kinase B(β) (Akt2) pathway is known to mediate insulin-stimulated glucose transport through increasing glucose transporter GLUT4 translocation from intracellular stores to the plasma membrane (PM). Combining quantitative phosphoproteomics with RNAi-based functional analyses, we show that a previously uncharacterized 138 kDa C2 domain-containing phosphoprotein (CDP138) is a substrate for Akt2, and is required for optimal insulin-stimulated glucose transport, GLUT4 translocation, and fusion of GLUT4 vesicles with the PM in live adipocytes. The purified C2 domain is capable of binding Ca(2+) and lipid membranes. CDP138 mutants lacking the Ca(2+)-binding sites in the C2 domain or Akt2 phosphorylation site S197 inhibit insulin-stimulated GLUT4 insertion into the PM, a rate-limiting step of GLUT4 translocation. Interestingly, CDP138 is dynamically associated with the PM and GLUT4-containing vesicles in response to insulin stimulation. Together, these results suggest that CDP138 is a key molecule linking the Akt2 pathway to the regulation of GLUT4 vesicle-PM fusion.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes / cytology
  • Adipocytes / drug effects
  • Adipocytes / metabolism*
  • Animals
  • Binding Sites
  • Calcium / metabolism
  • Cell Membrane / metabolism*
  • Gene Silencing / drug effects
  • Glucose Transporter Type 4 / metabolism*
  • Insulin / metabolism
  • Insulin / pharmacology*
  • Male
  • Mice
  • Peptides / pharmacology
  • Phosphoproteins* / antagonists & inhibitors
  • Phosphoproteins* / genetics
  • Phosphoproteins* / metabolism
  • Phosphorylation / drug effects
  • Protein Binding / drug effects
  • Protein Structure, Tertiary
  • Protein Transport / drug effects
  • Proteomics / methods*
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism*
  • RNA, Small Interfering / pharmacology
  • Signal Transduction / genetics*
  • Substrate Specificity
  • Transport Vesicles

Substances

  • Glucose Transporter Type 4
  • Insulin
  • Peptides
  • Phosphoproteins
  • RNA, Small Interfering
  • Slc2a4 protein, mouse
  • Akt2 protein, mouse
  • Proto-Oncogene Proteins c-akt
  • Calcium